DEFA14A: Masimo Battles Proxy Advisory Firms Amidst Activist Investor Challenge

Masimo is challenging the influence of proxy advisory firms ISS and Glass Lewis as Politan Capital Management seeks additional board seats.

Summary

• Masimo Corporation is contesting the recommendations of proxy advisory firms Institutional Shareholder Services (ISS) and Glass Lewis in the context of a proxy fight initiated by Politan Capital Management.
• Politan, already holding two board seats, aims to gain further control by nominating two additional candidates at Masimo's upcoming annual meeting.
• ISS and Glass Lewis have endorsed Politan's nominees, despite their perceived lack of industry experience.
• Masimo's board nominees include the company's founder/CEO, current chairman, and a former CEO with extensive experience in the medical device sector.
• Masimo argues that granting Politan control could jeopardize the company's innovation and future.
• The company highlights instances where ISS and Glass Lewis recommendations have not aligned with shareholder interests, citing examples such as the Walt Disney Company and Norfolk Southern.
• Masimo's CEO has stated he will step down if not re-elected, posing a risk of disruption.
• The company points to a study indicating that companies can lose up to 25% of their Total Shareholder Return (TSR) within a year of an activist attack.
• Masimo emphasizes its track record of market innovations and financial success under the current leadership.
• A California judge found Politan in contempt of court for distributing a news release of a sealed ruling in its proxy fight with Masimo.

Sentiment

Score: 4

Explanation: The document conveys a defensive stance, highlighting the risks associated with the activist investor's campaign and questioning the influence of proxy advisory firms. The sentiment is cautiously negative due to the uncertainty surrounding the proxy fight and its potential impact on the company's future.

Positives

• Masimo's board nominees include experienced leaders, including the company's founder/CEO and a former CEO with 30 years of industry experience.
• Masimo has a track record of market innovations and financial success.
• The company is actively challenging the influence of proxy advisory firms, advocating for a more balanced approach to corporate governance.

Negatives

• Politan Capital Management is seeking to gain control of Masimo's board.
• ISS and Glass Lewis have endorsed Politan's nominees, potentially undermining Masimo's current leadership.
• Masimo's CEO has stated he will step down if not re-elected, posing a risk of disruption.
• A California judge found Politan in contempt of court for distributing a news release of a sealed ruling in its proxy fight with Masimo.

Risks

• Granting Politan control could jeopardize Masimo's innovation and future.
• The potential loss of key personnel, including the CEO and engineers, if Politan's bid is successful.
• The distraction and cost associated with the ongoing proxy fight.
• The risk of a decline in shareholder value due to activist intervention.

Future Outlook

The document discusses the upcoming 2024 Annual Meeting of Stockholders and the potential outcomes of the proxy fight, but does not provide specific financial guidance or projections.

Management Comments

• Masimo's CEO has made it clear that he will follow the wishes of Masimo's shareholders and step down if not re-elected.

Industry Context

The document highlights the growing concern over the influence of proxy advisory firms like ISS and Glass Lewis, particularly in the context of activist investor campaigns targeting small and mid-cap companies. It suggests a trend of institutional investors seeking alternatives to these firms due to concerns about accuracy and bias.

Comparison to Industry Standards

• The document references the Walt Disney Company and Norfolk Southern as examples where ISS and Glass Lewis recommendations did not align with shareholder interests, suggesting that Masimo's situation is not unique.
• The document cites a Boston Consulting Group finding that companies lose up to 25% of their Total Shareholder Return (TSR) within a year of an activist attack, implying that Masimo could face similar consequences if Politan's campaign is successful.
• BlackRock's recent addition of Egan Jones as a third proxy advisor is a telling and welcome sign of market participants rejecting the pair of handcuffs that is the proxy advisory duopoly.

Legal Proceedings

• A California judge found Politan in contempt of court for distributing a news release of a sealed ruling in its proxy fight with Masimo.

Stakeholder Impact

• Shareholders face uncertainty regarding the future direction of the company and the potential impact on shareholder value.
• Employees may be concerned about potential changes in leadership and strategy.
• Customers could be affected by any disruptions to Masimo's innovation and product development.

Next Steps

• The 2024 Annual Meeting of Stockholders will proceed, where shareholders will vote on the election of directors.
• Masimo will continue to advocate for its board nominees and challenge the recommendations of ISS and Glass Lewis.

Key Dates

Keywords

Masimo, Politan Capital Management, Proxy Fight, ISS, Glass Lewis, Activist Investor, Corporate Governance, Board Election, Shareholder Value, Medical Device